|
Age at start (year)
|
53 ± 12.1/53 [43–61]
|
|
Gender
|
|
men
|
112 (84.8%)
|
|
women
|
20 (15.2%)
|
|
Etiology
|
|
Hepatitis B
|
109 (82.6%)
|
|
Hepatitis C
|
6 (4.5%)
|
|
Others
|
17 (12.9%)
|
|
Child-Pugh class
|
|
A
|
124 (93.9%)
|
|
B
|
8 (6.1%)
|
|
Performance status
| |
|
ECOG 0
|
85 (64.4%)
|
|
ECOG 1
|
47 (35.6%)
|
|
BCLC stage
|
|
A
|
10 (7.6%)
|
|
B
|
75 (56.8%)
|
|
C
|
47 (35.6%)
|
|
Tumor burden
|
|
Tumor size (cm)
|
8.0 ± 3.7/7.1 [5.2–9.8]
|
|
No. of HCC nodules
|
2.1 ± 1.9/1 [1–2.25]
|
|
AFP (ng/dl)
|
1188.4 ± 2774.7/230.8 [8.7–7713.5]
|
|
Leukocyte (×10E9/L)
|
5.9 ± 2.7/5.3 [4.2–6.9]
|
|
Hemoglobin (g/L)
|
136.5 ± 20.6/138.0 [126.0–192.5]
|
|
Platelets (×10E9/L)
|
150.1 ± 89.3/134.0 [91.0–192.3]
|
|
International normalized ratio
|
1.16 ± 0.13/1.10 [1.02–1.17]
|
|
Alanine aminotransferase (U/L)
|
45.6 ± 32.3/37 [24.5–57.0]
|
|
Aspartate aminotransferase (U/L)
|
53.1 ± 32.7/40.5 [30–69.5]
|
|
Albumin (g/L)
|
39.7 ± 5.3/39.8 [36.6–42.5]
|
|
Total bilirubin (μmol/L)
|
16.6 ± 6.8/15.3 [11.6–19.6]
|
|
Urea nitrogen (mmol/L)
|
5.2 ± 1.7/4.8 [4.2–6]
|
|
Serum creatinine (umol/L)
|
84.2 ± 15.9/82.5 [73.8–95.0]
|
